Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor II”

815 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 815 results

Very early researchStudy completedNCT04130152
What this trial is testing

Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 22
Testing effectiveness (Phase 2)Looking for participantsNCT07303894
What this trial is testing

Isoquercetin in People With Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerSerous Ovarian Tumor
Memorial Sloan Kettering Cancer Center 90
Not applicableEnded earlyNCT02525887
What this trial is testing

Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways

Who this might be right for
Chronic DiseaseEndocrine System DiseaseCardiovascular Disease+2 more
Bracane Company 80
Testing effectiveness (Phase 2)Study completedNCT02321540
What this trial is testing

A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT06892548
What this trial is testing

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Who this might be right for
Advanced Lung Cancer
BioNTech SE 594
Testing effectiveness (Phase 2)Ended earlyNCT01928615
What this trial is testing

Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 2
Not applicableWithdrawnNCT01462968
What this trial is testing

Interruptions in the Coagulationsystem in Relation With Cardiac Surgery - A Study Comparing Two Heparinization Strategies During On-pump Cardiac Surgery

Who this might be right for
Cardiac Surgery
Aalborg University Hospital
Not applicableStudy completedNCT03034850
What this trial is testing

Thrombin Generation and Platelet Activation in CRS/HIPEC

Who this might be right for
Mesothelioma; PeritoneumPseudomyxoma PeritoneiPeritoneal Carcinomatosis
Ziekenhuis Oost-Limburg 27
Testing effectiveness (Phase 2)Study completedNCT02646020
What this trial is testing

Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 138
Not applicableStudy completedNCT02300519
What this trial is testing

Thrombin Generation Numerical Models Validation in Haemophilic Case

Who this might be right for
Haemophilia BHaemophilia A
Centre Hospitalier Universitaire de Saint Etienne 40
Testing effectiveness (Phase 2)Looking for participantsNCT06156527
What this trial is testing

Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & Smoker

Who this might be right for
Lazertinib
National Cancer Center, Korea 120
Testing effectiveness (Phase 2)Study completedNCT00508924
What this trial is testing

Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)

Who this might be right for
Coronary Artery DiseaseAngina, Unstable
Tanabe Pharma Corporation 140
Testing effectiveness (Phase 2)Study completedNCT04246489
What this trial is testing

Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
EMD Serono Research & Development Institute, Inc. 146
Testing effectiveness (Phase 2)UnknownNCT03797391
What this trial is testing

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

Who this might be right for
NeoplasmsNeoplasm MetastasisNon-Small-Cell Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd. 186
Testing effectiveness (Phase 2)UnknownNCT04675008
What this trial is testing

Central Nervous System(CNS) Efficacy of Dacomitinib

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Samsung Medical Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06492317
What this trial is testing

RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer

Who this might be right for
HER2-positive Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 20
Not applicableUnknownNCT01078792
What this trial is testing

Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

Who this might be right for
Pulmonary Disease, Chronic ObstructiveDisease ExacerbationPulmonary Embolism+1 more
Hillel Yaffe Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449209
What this trial is testing

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Who this might be right for
Extensive-stage Small-cell Lung CancerSmall-cell Lung Cancer
BioNTech SE 110
Testing effectiveness (Phase 2)Study completedNCT01164007
What this trial is testing

Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 40
Not applicableStudy completedNCT03313531
What this trial is testing

Evaluation of a Standardized Protocol for Thrombin Generation Assay

Who this might be right for
Hemophilia A
Lund University 9
Load More Results